• High-Throughput BBB Permeability: LLC-PK1-MOCK/MDR1 Model Ad

  2026-05-20

  Hu et al. introduce a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK and LLC-PK1-MDR1 cells, integrating lysosomal trapping correction to improve prediction of brain permeability for CNS drugs. This model demonstrates robust predictive accuracy and streamlines early-stage compound screening, offering a practical alternative to labor-intensive in vivo assessments.

• Cytoskeleton-Dependent Autophagy under Mechanical Stress: Ne

  2026-05-20

  This study uncovers the pivotal role of the cytoskeleton, particularly microfilaments, in mediating autophagy triggered by mechanical stress in human cells. The findings clarify mechanotransduction pathways and provide mechanistic context for researchers investigating calcium signaling and cellular homeostasis.

• One-step TUNEL Cy3 Kit: Precision Apoptosis Detection in Tra

  2026-05-19

  Discover how the One-step TUNEL Cy3 Apoptosis Detection Kit enables precise, translational detection of DNA fragmentation and apoptosis, uniquely bridging mechanistic insight with clinical relevance in liver injury models. Explore advanced protocols and the latest research-driven guidance.

• Melittin: Bioactive Peptide Workflows for Cancer Signal Modu

  2026-05-19

  Melittin stands out as a dual Gs inhibitor and Gi activator, providing a unique lever for dissecting cell signaling and apoptosis in cancer research. This guide details optimized workflows, troubleshooting strategies, and experimental insights that leverage Melittin's precision for high-impact studies in signal transduction and glioblastoma biology.

• High-Throughput Ionizable Lipid Optimization for mRNA Delive

  2026-05-18

  Li et al. (2024) introduce a high-throughput A3 coupling approach to synthesize and screen 623 ionizable lipids, elucidating precise structure–function relationships that dictate mRNA delivery efficiency. Their findings guide rational lipid nanoparticle design to enhance therapeutic and reporter mRNA delivery, with practical implications for gene regulation and in vivo imaging studies.

• CDK4 Phosphorylation of 4E-BP1: Chemoproteomic Insights in C

  2026-05-18

  Mitchell et al. (2019) introduce a chemoproteomic pipeline that identifies CDK4 as a novel kinase for 4E-BP1, revealing a critical mechanism underlying mTORC1-inhibitor resistance in breast cancer. Their phosphosite-specific mapping of kinase-substrate interactions advances our understanding of translational control and therapeutic targeting in oncogenic pathways.

• Diuron (SKU C6731): Reliable Toxicology & Cell Assay Researc

  2026-05-17

  This article delivers scenario-driven guidance for using Diuron (SKU C6731) in toxicology and cell viability assays, emphasizing evidence-based protocol optimization, data interpretation, and product reliability. Targeted at biomedical researchers and laboratory technicians, it addresses real-world workflow challenges and illustrates how APExBIO's Diuron underpins reproducible and sensitive toxicological studies.

• Caspase-3 Fluorometric Assay Kit: Precision Apoptosis Assays

  2026-05-16

  Unlock robust, quantitative detection of apoptosis with the Caspase-3 Fluorometric Assay Kit. This guide delivers advanced workflow strategies, troubleshooting insights, and practical integration of the latest caspase research for reliable cysteine-dependent aspartate-directed protease analysis.

• Imatinib (STI571): Selective Kinase Inhibition in CML NET Re

  2026-05-15

  Explore the advanced role of Imatinib (STI571) in dissecting neutrophil extracellular trap (NET) biology within chronic myeloid leukemia research. This article uniquely bridges kinase pathway inhibition with translational assay design, providing deeper scientific context for signal transduction research.

• Sulfo-NHS-LC-Biotin: Protocols for Cell Surface Protein Biot

  2026-05-15

  Sulfo-NHS-LC-Biotin enables stable, covalent biotin labeling of primary amines on proteins in aqueous environments, specifically targeting cell surface proteins due to its membrane-impermeable properties. It is not suitable for reversible or intracellular biotinylation workflows and should be reserved for applications requiring permanent, extracellular modification.

• EdU Imaging Kits (488): Elevating S-Phase Proliferation Insi

  2026-05-14

  This article explores the mechanistic superiority and translational impact of EdU Imaging Kits (488) for cell proliferation assays, with strategic guidance for researchers in oncology and beyond. By integrating evidence from the latest in click chemistry, comparative performance data, and next-generation therapeutic platforms like implantable Tumor Treating Field (i-TTF) systems, we contextualize EdU-based S-phase DNA synthesis measurement as a cornerstone for both experimental rigor and clinical progress. The discussion is advanced beyond prior reviews by explicitly connecting high-fidelity proliferation quantification to the evolving demands of in vivo translational cancer research.

• Pexidartinib (PLX3397) for Tumor Microenvironment Modulation

  2026-05-14

  Pexidartinib (PLX3397) enables precise modulation of tumor microenvironment macrophages through selective CSF1R inhibition, supporting robust anti-tumor research workflows. Discover how optimized protocols and troubleshooting insights empower investigators to translate macrophage-targeted strategies into reproducible, high-impact cancer research outcomes.

• Sequential BCL-XL and MCL-1 Inhibition Sensitizes Glioblasto

  2026-05-13

  This study reveals that glioblastoma (GBM) cells exhibit elevated anti-apoptotic BCL-XL and MCL-1 expression, making them particularly sensitive to BH3-mimetic agents targeting these proteins. Sequential inhibition of BCL-XL and MCL-1 in GBM models results in robust apoptosis and tumor suppression, highlighting a promising approach to overcome therapeutic resistance in aggressive brain tumors.

• CKI 7 dihydrochloride: Precision Casein Kinase 1 Inhibition

  2026-05-13

  CKI 7 dihydrochloride empowers researchers with selective Casein kinase 1 inhibition, enabling robust dissection of CK1-dependent pathways in cancer biology and circadian rhythm studies. This article delivers expert guidance for experimental design, workflow optimization, and troubleshooting, with direct protocol recommendations and evidence-based use-case differentiation.

• Organic Cation Transporter Response to Xenobiotics in Aedes

  2026-05-12

  Kennel and Rouhier's 2025 study systematically examined how Aedes aegypti mosquitoes process and excrete various xenobiotic dyes, including the mesalamine dimer Olsalazine Sodium. Their findings reveal that while organic cation transporter gene expression changes were limited, the molecular structure of the xenobiotic significantly influenced excretion patterns and mosquito mortality, suggesting new molecular targets for vector control.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page